Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
April 23, 2021
Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering
April 22, 2021
Pear Announces Ohio Department of Mental Health and Addiction Services Will Provide Access to Prescription Digital Therapeutics to Help Local Communities Continue to Fight Against Opioid Addiction
April 21, 2021
Northwell Health Teams with Pear Therapeutics to Provide New Treatment for Patients with Substance Use Disorders
April 21, 2021
Precision NanoSystems Announces New Cell Therapy Reagent for Lipid Nanoparticle-based mRNA Delivery to T Cells
April 19, 2021
IDEAYA Reports Darovasertib (IDE196) Monotherapy Overall Survival Data and Observes Early Partial Responses in Binimetinib Combination in Metastatic Uveal Melanoma
April 15, 2021
IDEAYA Announces Dosing of First Patient of MAT2A Inhibitor IDE397 in Phase 1 Clinical Trial Evaluating MTAP-Deletion Solid Tumors
April 15, 2021
Scientist.com Recognized as One of The America’s Fastest Growing Companies by The Financial Times
April 14, 2021
Marvin, Halio Inc. Announce Exclusive Agreement to Bring Halio® Smart Glass to Residential Market
April 13, 2021
Kinestral Technologies, Inc. Announces Widely-Recognized Halio Product Name as New Corporate Identity
April 13, 2021
Akouos Receives Orphan Drug and Rare Pediatric Disease Designations for AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss
« Previous Page
1
…
39
40
41
42
43
…
118
Next Page »